Skip to main content

Editorial Board

Editor-in-Chief
Yongchao Su, PhD, Merck, West Point, PA, USA
yongchao.su@merck.com 

Editors                                 
Xiuling Lu, PhD, FAAPS, University of Connecticut, Storrs, CT, USA
Mohammed Maniruzzaman, PhD, University of Mississippi, Oxford, MS, USA 
Dana Moseson, PhD, Pfizer, Groton, Connecticut, USA
Yihong Qiu, PhD, AbbVie, Vernon Hills, IL, USA 
Chun-Wan Yen, PhD, Genentech, San Francisco, CA, USA 
                                               
Editorial Advisory Board                           
Ian Blagbrough, PhD, University of Bath, Bath, UK
Ahmed Besheer, PhD, Lonza, Basel, Switzerland
Kaushalendra Chaturvedi, PhD, J-STAR Research Inc., Cranbury, NJ, USA 
Kang Chen*, PhD, Food and Drug Administration, Silver Springer, MD, USA
*Serving in their personal capacity
David Cipolla, MD, Insmed Incorporated, New York City, NY, USA 
Ana Sara Cordeiro, PhD, De Montfort University, Leicester, UK
Tapan Das, PhD, Spyre Therapeutics, Princeton, NJ, USA
Binodh DeSilva, PhD, Ultragenyx, Princeton, NJ, USA
Vivian Gray, BSc, VA Gray Consulting, Hockessin, DE, USA
Timothy Hickling, PhD, Roche/Genentech, Basel, Switzerland
Kim Huynh-Ba, PhD, Pharmalytik, Newark, DE USA
Hyunyoung Jeong, PharmD, PhD, Purdue University, West Lafayette, IN, USA
Tarik Khan, PhD, Roche / Genentech, Basel, Switzerland
Lakshmi Prasanna, PhD, Astra Zeneca, UK
John Lough, BSc, PhD, CChem, FRSC, FChromSoc, School of Pharmacy and Pharmaceutical Sciences, University of Sunderland, UK
Christopher McCurdy, PhD, BSPh, FAAPS, University of Florida, , USA
Ehab Moussa, PhD, Abbvie, North Chicago, IL, USA
Sakya Mohapatra, ReCode Therapeutics, San Francisco, CA, USA 
Arnab Mukherjee, PhD, Pfizer, New London, CT USA
Anette Müllertz, PhD, University of Copenhagen, Copenhagen, Denmark
Douhai Pan, Bristol Myers Squibb, New Brunswick, NJ USA
Komal Patel, MS, Kenox Pharmaceuticals
Changquan Calvin Sun, PhD, University of Minnesota, Minnesota, MN, USA
Harsh Shah, PhD, J-STAR Research Inc., New Jersey, US
Mehran Yazdanian, BSc, Teva Branded Pharmaceutical Products R&D Inc., USA
Qi (Tony) Zhou, PhD, Purdue University, USA 

AAPS
Matthew Baughman, AAPS, United States of America

 

Affiliated with

Annual Journal Metrics

  • Speed 2023
    Submission to first editorial decision (median days): 13
    Submission to acceptance (median days): 96

    Usage 2023
    Downloads: 167,495
    Altmetric mentions: 29